Quantitative comparison of macular segmentation performance using identical retinal regions across multiple spectral-domain optical coherence tomography instruments

British Journal of Ophthalmology

Volumn 99, Issue 6, 2015, Pages 794-800

  Waldstein, Sebastian M ^a   Gerendas, Bianca S ^a   Montuoro, Alessio ^a   Simader, Christian ^a   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

A SCAN; ADULT; ALGORITHM; ARTICLE; B SCAN; CENTRAL MACULAR THICKNESS; CENTRE POINT THICKNESS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ERROR; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; MEASUREMENT ACCURACY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE STUDY; SEGMENTATION ERROR; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS; ARTIFACT; DEVICES; DIABETIC RETINOPATHY; DIAGNOSTIC ERROR; EPIRETINAL MEMBRANE; MACULAR DEGENERATION; MACULAR EDEMA; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; REPRODUCIBILITY; RETINA; RETINAL DISEASES; RETINAL VEIN OCCLUSION; THREE DIMENSIONAL IMAGING; WET MACULAR DEGENERATION;

ALGORITHMS; ARTIFACTS; DIABETIC RETINOPATHY; DIAGNOSTIC ERRORS; EPIRETINAL MEMBRANE; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MACULAR DEGENERATION; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL DISEASES; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; WET MACULAR DEGENERATION;

EID: 84930383602     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2014-305573     Document Type: Article

References (25)

1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-81.
2. Fercher AF, Hitzenberger CK, Drexler W, et al. In vivo optical coherence tomography. Am J Ophthalmol 1993;116:113-14.
3. Wojtkowski M, Leitgeb R, Kowalczyk A, et al. In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt 2002;7:457-63.
4. Geitzenauer W, Hitzenberger CK, Schmidt-Erfurth UM. Retinal optical coherence tomography: past, present and future perspectives. Br J Ophthalmol 2011;95:171-7.
5. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessment of macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019-29.
6. Hee MR, Baumal CR, Puliafito CA, et al. Optical coherence tomography of age-related macular degeneration and choroidal neovascularization. Ophthalmology 1996;103:1260-70.
7. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-83.
8. Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124-33.e1.
9. Campochiaro PA, Heier JS, Feiner L, et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102-12.e1.
10. Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118:615-25.
11. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006;113:285-93.
12. Krebs I, Haas P, Zeiler F, et al. Optical coherence tomography: limits of the retinal-mapping program in age-related macular degeneration. Br J Ophthalmol 2008;92:933-5.
13. Ho J, Sull AC, Vuong LN, et al. Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology 2009;116:1960-70.
14. Mylonas G, Ahlers C, Malamos P, et al. Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration. Br J Ophthalmol 2009;93:1453-60.
15. Patel PJ, Chen FK, da Cruz L, et al. Segmentation error in stratus optical coherence tomography for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:399-404.
16. Keane PA, Mand PS, Liakopoulos S, et al. Accuracy of retinal thickness measurements obtained with Cirrus optical coherence tomography. Br J Ophthalmol 2009;93:1461-7.
17. Krebs I, Falkner-Radler C, Hagen S, et al. Quality of the threshold algorithm in age-related macular degeneration: stratus versus cirrus OCT. Invest Ophthalmol Vis Sci 2009;50:995-1000.
18. Han IC, Jaffe GJ. Evaluation of artifacts associated with macular spectral-domain optical coherence tomography. Ophthalmology 2010;117:1177-89.e4.
19. Giani A, Cigada M, Esmaili DD, et al. Artifacts in automatic retinal segmentation using different optical coherence tomography instruments. Retina 2010;30:607-16.
20. Modjtahedi S, Chiou C, Modjtahedi B, et al. Comparison of Macular Thickness Measurement and Segmentation Error Rate Between Stratus and Fourier-Domain Optical Coherence Tomography. Ophthalmic Surg Lasers Imaging 2010;41:301.
21. Malamos P, Ahlers C, Mylonas G, et al. Evaluation of segmentation procedures using spectral domain optical coherence tomography in exudative age-related macular degeneration. Retina 2011;31:453-63.
22. Krebs I, Smretschnig E, Moussa S, et al. Quality and reproducibility of retinal thickness measurements in two spectral domain optical coherence tomography machines. Invest Ophthalmol Vis Sci 2011;52:6925-33.
23. Matt G, Sacu S, Buehl W, et al. Comparison of retinal thickness values and segmentation performance of different OCT devices in acute branch retinal vein occlusion. Eye 2011;25:511-18.
24. Song Y, Lee BR, Shin YW, et al. Overcoming Segmentation Errors in Measurements of Macular Thickness Made By Spectral-Domain Optical Coherence Tomography. Retina 2012;32:569-80.
25. Keane PA, Liakopoulos S, Jivrajka RV, et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:3378-85.